# A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days

> **NCT01116258** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 60 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD5847
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01116258
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116258, "A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01116258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*